UnknownNot Applicable

Comparison Between Bladder Dissection Before and After Uterine Incision in Cesarean Section for Morbidly Adherent Placenta

Egypt60 participantsStarted 2018-03-31

Plain-language summary

Comparison between bladder dissection at the beginning of cesarean section For morbidly adherent placenta and between delaying dissection until planning for cesarean hysterectomy

Who can participate

Age range

18 Years – 50 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Women with BMI at or under 35 Kg/m2.
. Women having previous two cesarean section or more.
. Women with gestational age more than 32 weeks with viable fetus.
. Women with any degree of placenta previa .
. Patient with morbidly adherent placenta on cesarean scar only.

Exclusion criteria

. Patient who are haemodynamically unstable before skin incision.
. Patient with clinically evident intraamniotic infection.
. Patient with previous history of bladder injury .

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Operative time

Timeframe: icluding all cs over the period of one year

Blood loss

Timeframe: icluding all cs over the period of one year

- Incidence of urological

Timeframe: during cs and post operative delayed complication icluding all cs over the period of one year

Trial details

NCT IDNCT03676855

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-02-01

Contact for this trial

hassan helmy, master

01023308711 saberaleek2222@yahoo.com

View on ClinicalTrials.gov More Morbidly Adherent Placenta trials